New era for ME/CFS research as top cytokine study attracts media headlines
The immune systems of patients who have recently developed ME/CFS look markedly different from those who have been ill for much longer, according to a major new study from Drs. Ian Lipkin and Mady Hornig at Columbia University. This shift in immune function hadn’t been seen before.
Discuss the article on the Forums.

IOM has very weak quality control

Discussion in 'Institute of Medicine (IOM) Government Contract' started by Andrew, Nov 28, 2013.

  1. Andrew

    Andrew Senior Member

    Messages:
    2,022
    Likes:
    1,428
    Los Angeles, USA
    The way their process is set up.

    Let's say we found clearly incorrect information in an early draft from the panel, and we showed them evidence that proved it, but they said "Well, the CDC says otherwise, and even if they don't offer evidence, we can't see any reason why they would lie." And then they refuse to correct their decision. Nothing can be done. Even if the entire IOM staff and review board agrees with us, the mistakes will not be corrected. The panel has ultimate authority, right or wrong. And the IOM set it up to work this way.
     
  2. peggy-sue

    peggy-sue

    Messages:
    2,622
    Likes:
    3,145
    Scotland
    It's the same with governments here.
    They employ outside experts to give them scientific evidence - and if the government doesn't like the evidence, they sack the experts and carry on ignoring the facts.
     

See more popular forum discussions.

Share This Page